GENZYME (GENZ) – FDA
-
Sanofi (SNY) Says New Data to be Presented at AAN Suggest Positive Effects of Aubagio on Cortical Gray Matter Atrophy
-
Sanofi Genzyme's (SNY) New Investigational Data on Lemtrada Six-Year Efficacy in MS to be Presented at AAN
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to GENZ Stock Lookup